Most of the mRNA from a COVID-19 vaccine is broken down within days after injection, and the protein it produces becomes undetectable in the blood within a few weeks for the vast majority of people. In one detailed human study, vaccine mRNA peaked in the blood one to two days after a booster shot and then dropped sharply, though small amounts remained measurable in about a third of participants at the two-week mark. The timeline is more nuanced than a single number can capture, because “the vaccine” is really several components, each with its own clock.
Where the Vaccine Goes After You Get the Shot
When an mRNA vaccine is injected into your upper arm muscle, the lipid nanoparticle (LNP) shell carries the mRNA into nearby cells. Imaging studies in mice and non-human primates show that LNPs spread through the injected muscle tissue almost immediately, and within about six hours they show up in draining lymph nodes, the small immune-system hubs near the injection site. That speed suggests they drain there through lymphatic channels rather than being ferried by immune cells, which would take longer.1Molecular Therapy. Quantitative whole-animal tracking of mRNA/lipid nanoparticle vaccine biodistribution in live mice and non-human primates
The injection site and nearby lymph nodes consistently receive the highest exposure. Rat studies measuring total tissue exposure across multiple Moderna drug products found that the injection site and draining lymph nodes had the highest concentrations by a wide margin. The liver, the organ most commonly flagged in biodistribution discussions, received only about 3% of the exposure measured at the injection site. Other organs like the brain, heart, lungs, bone marrow, and reproductive tissues each received less than 1% of the injection-site exposure.2Molecular Therapy Nucleic Acids. Biodistribution, pharmacokinetics, and clearance of mRNA-lipid nanoparticle vaccines and their expressed antigen In a separate study using a self-amplifying mRNA platform in mice, mRNA was detectable in the spleen, lungs, heart, kidney, and liver on day one, but by day three it had already become undetectable in the liver, and by day seven it was found only in the spleen and the injection site. At no point was mRNA detected in the brain.3npj Vaccines. Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza
How Quickly the mRNA Itself Breaks Down
Messenger RNA is inherently fragile. In the body, enzymes called ribonucleases chew up free-floating mRNA efficiently, which is one reason the lipid shell is necessary in the first place. Once the LNP delivers its cargo into a cell and the mRNA starts being translated into spike protein, the cellular machinery degrades it through normal turnover. This is true of all mRNA in your cells, not just vaccine mRNA.
The vaccines do use chemical modifications to make the mRNA last a bit longer than a completely natural strand would. Substituting certain building blocks, such as replacing uridine with pseudouridine, delays recognition by the immune system and slows enzymatic breakdown. Research on modified mRNA in animals has shown that these changes can meaningfully extend protein production compared to unmodified mRNA, which tends to be destroyed almost immediately while triggering a strong innate immune response.4Springer Nature – PMC. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency But “longer” in this context still means days, not months. In non-human primates, protein expression from injected mRNA peaked at 24 hours and remained detectable for about a week.5Molecular Therapy. mRNA vaccine trafficking and resulting protein expression after intramuscular administration
The human data largely lines up. In a study of 19 people who received a Moderna bivalent booster, vaccine mRNA was found in the plasma of every participant at four hours after the shot. It peaked at about one to two days and then declined in a log-linear pattern, meaning it dropped by roughly the same proportion each day. By day 14 or 15, only 7 of the 19 participants still had quantifiable mRNA in their plasma, and the concentrations in those people were very low.6PubMed Central. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans That roughly two-week window in blood is consistent with what autopsy studies have found in tissue: vaccine mRNA was detected in the axillary lymph nodes of most patients who died within 30 days of vaccination, but in none of those who died after 30 days.7npj Vaccines. Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
The Lipid Shell Clears Fast Too
People often focus on the mRNA, but the lipid nanoparticle that carries it is also a foreign substance worth tracking. The good news is that LNP components are metabolized and excreted quickly. In a detailed rat study using radiolabeled Lipid 5, the ionizable lipid used in Moderna’s formulation, intact lipid was mostly cleared from blood plasma within 10 hours. The body broke it down through a straightforward process: enzymes split the ester bonds in the lipid tail, producing smaller fragments that were further oxidized. Over 90% of the administered lipid was recovered in urine and feces, mostly as breakdown products, within 72 hours.8Drug Metabolism and Disposition. Systemic Exposure, Metabolism, and Elimination of [14C]-Labeled Amino Lipid, Lipid 5, after a Single Administration of mRNA Encapsulating Lipid Nanoparticles to Sprague-Dawley Rats
After intravenous injection, which pushes far more material into the bloodstream than the standard intramuscular route, radiolabeled lipid peaked in most tissues within an hour and was concentrated in the liver and intestines by 24 hours, consistent with the body routing it through its standard waste-processing pathways. By seven days, the lipid and all its breakdown products were completely cleared.9Drug Metabolism and Disposition. Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in Rats Studies in non-human primates similarly showed rapid hepatic clearance of biodegradable lipid components from the liver.10PubMed. Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates
Spike Protein Has a Different Timeline
The mRNA does not work on its own. Its job is to instruct cells to build spike protein, and that protein is what trains the immune system. The spike protein timeline is related to but distinct from the mRNA timeline, because protein can linger after the mRNA template that made it is already gone.
In the blood, spike protein subunits have been detected on the surface of tiny vesicles called exosomes starting around 14 days after the first dose, with levels increasing after the second dose. These exosomes carrying spike protein, along with antibodies directed against it, declined in parallel over the following months and were diminished by about four months.11The Journal of Immunology. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer–BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines This four-month window is longer than the mRNA itself persists, but it reflects the immune system’s ongoing processing and presentation of the antigen, not continued production of new spike protein from fresh mRNA.
A separate clinical study noted something unusual in a small group of adolescents and young adults who developed myocarditis after vaccination: they had elevated levels of free spike protein in their blood, while healthy vaccinated controls did not have detectable free spike.12PubMed Central. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis This does not mean the vaccine lingered longer in those individuals; the leading hypothesis is that something about the immune response in those cases allowed spike protein to escape antibody binding, rather than it being produced for an unusually long time. Still, it underscores that the clearance timeline can vary from person to person.
The Lymph Node Response Outlasts Everything Else
Even after the mRNA is gone and spike protein levels in the blood have dropped to undetectable, the immune system keeps working in the lymph nodes. This is by design. A study that sampled draining axillary lymph nodes using fine-needle aspirates found that specialized immune cells called germinal centre B cells, which bind the spike protein and refine antibodies against it, were still present at or near their peak frequency 15 weeks after vaccination in 8 out of 10 participants.13Nature. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Follow-up work found that two-thirds of participants still had detectable antigen-specific germinal centre B cells in their lymph nodes at 29 weeks, roughly six months after vaccination. The study also found bone-marrow plasma cells that could secrete spike-binding antibodies in most participants, the kind of long-lived cells that form the basis of durable immunity.14Nature. Germinal centre-driven maturation of B cell response to mRNA vaccination This persistent germinal centre activity is not a sign that vaccine material is still hanging around. It reflects the immune system continuing to mature and improve its response to the antigen it encountered months earlier, a normal and desirable process.
Does a Second Dose Cause Accumulation?
A reasonable question is whether getting multiple doses causes vaccine components to pile up in tissues. Rat studies that examined a second dose given about four weeks after the first found no evidence of accumulation. The peak blood levels and tissue concentrations of both mRNA and lipid were statistically the same after the first and second doses. The biodistribution pattern was also the same, with the injection site and lymph nodes receiving the most exposure and distal tissues receiving very little.2Molecular Therapy Nucleic Acids. Biodistribution, pharmacokinetics, and clearance of mRNA-lipid nanoparticle vaccines and their expressed antigen This makes sense given that the first dose’s components are cleared well before the second dose arrives, so there is nothing left to stack on top of.
The Breast Milk Question
Lactating parents have understandably wanted to know whether vaccine mRNA passes into breast milk. Two studies looked at this with sensitive detection methods and reached reassuring conclusions. One study analyzing 40 milk samples from vaccinated women found no detectable mRNA in 90% of them. The few samples that did test positive, all collected within the first week after a dose, contained extremely low concentrations. Even in a worst-case scenario using the highest level detected, the researchers estimated that about 0.7% of the original vaccine dose would transfer in 100 milliliters of milk.15npj Vaccines. Codominant IgG and IgA expression with minimal vaccine mRNA in milk of BNT162b2 vaccinees A separate study that sampled milk between 4 and 48 hours after vaccination with either the Pfizer or Moderna vaccine detected no mRNA at all, supporting the recommendation from major health organizations that vaccinated parents should continue breastfeeding without interruption.16medRxiv. COVID-19 mRNA vaccine is not detected in human milk
Rare Cases Where mRNA Shows Up in Unexpected Places
Most of the evidence points to a tidy timeline: mRNA stays near the injection site and lymph nodes, does its job, and gets cleaned up. But rare case reports have documented exceptions. In one case of vaccine-associated hepatitis, researchers used highly sensitive in situ hybridization and found mRNA encoding the spike protein inside liver cells. The finding suggests that under certain circumstances, lipid nanoparticles can reach the liver and deliver mRNA to hepatocytes in amounts large enough to drive local protein production.17PubMed Central. In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis This aligns with biodistribution data showing that the liver, while receiving far less exposure than the injection site, consistently ranks highest among the organs not directly connected to the injection or lymphatic drainage.
A review paper has also noted that modified SARS-CoV-2 mRNA has been reported to persist for up to about a month after injection in some clinical observations, and that recombinant spike protein has been detected in blood for longer, on the order of several months.18PubMed Central. Long-lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID-19 vaccination The persistence of spike protein beyond the mRNA’s lifespan likely reflects the immune system’s ongoing handling of the antigen rather than continuous production. Still, these longer-than-expected detection windows are the kind of edge case that researchers are continuing to study.
Can the mRNA Change Your DNA?
One of the most persistent concerns about mRNA vaccines is whether the injected RNA could somehow integrate into human chromosomes. The mRNA delivered by COVID-19 vaccines works in the cytoplasm, the outer compartment of the cell, and does not need to enter the nucleus where DNA is stored. Human cells do not ordinarily have the machinery to reverse-transcribe mRNA back into DNA and stitch it into the genome.
One in-vitro study did report that a human retrotransposon called LINE-1, which is normally silenced, became active in a liver cell line exposed to vaccine mRNA, leading to reverse transcription of vaccine sequences.19PubMed Central. Potential health risks of mRNA-based vaccine therapy: A hypothesis That study was widely discussed but has important limitations: it used a cancer-derived cell line with abnormal gene expression, and the conditions did not reflect what happens in a living person. A separate study that specifically looked for genomic integration of reverse-transcribed mRNA in cells found none, even up to seven days after transfection.20Biochemical and Biophysical Research Communications. Evaluation of self-amplifying mRNA platform for protein expression and genetic stability: Implication for mRNA therapies No study in living animals or humans has demonstrated that vaccine mRNA integrates into the genome.
How Individual Variation Shapes the Timeline
Not everyone clears the vaccine at the same rate, and the human data make that clear. In the study of 19 booster recipients, the peak blood concentration of mRNA varied roughly twentyfold between individuals, from about 0.005 to 0.529 nanograms per milliliter. Some people cleared it from their blood by day seven, while others still had measurable amounts at day 14 or 15.6PubMed Central. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans The reasons for this variation are not fully understood, but likely involve differences in injection technique, local blood flow, body composition, and the efficiency of each person’s ribonucleases and immune cells in breaking things down.
What the data consistently show is that even the slowest clearers are dealing with tiny amounts of residual material. The concentrations measured at the tail end of the detection window are orders of magnitude lower than what was present at the peak. And the fact that these later measurements bump up against the lower limit of what the assays can detect tells you something about the scale: the amounts still present at two weeks are not biologically active in the way they were during the first couple of days.
Self-Amplifying RNA Platforms
A newer vaccine technology uses self-amplifying RNA (saRNA), which includes an enzyme that can copy the RNA strand inside the cell. The goal is to get robust protein production from a much smaller starting dose. Preclinical studies have shown that saRNA vaccines can induce immune responses comparable to standard mRNA vaccines but at lower doses.21PubMed Central. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19 The biodistribution data for these platforms follow a broadly similar pattern to conventional mRNA vaccines. In one mouse study, self-amplifying RNA was detectable at the injection site and spleen out to day seven but disappeared from the liver by day three, and it was never found in the brain.3npj Vaccines. Immunogenicity and biodistribution of lipid nanoparticle formulated self-amplifying mRNA vaccines against H5 avian influenza Because the RNA replicates itself inside the cell, even a small amount can drive antigen production for a similar window. The tradeoff researchers are still working through is whether the amplification step affects how long antigen persists in tissue or whether it changes the immune signaling in ways that matter for safety or durability.